Ani Pharmaceuticals (ANIP) Gross Margin Growth (3y) (2015 - 2026)

Ani Pharmaceuticals (ANIP) Gross Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 631.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -675.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 7,053.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 33.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -344.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -37,361.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1,517.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,557.00
10 Ani Pharmaceuticals 1.71 Bn 1.40 Bn 143.88 Mn -410.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -410.00
Dec 31, 2025 -204.00
Sep 30, 2025 -175.00
Jun 30, 2025 1,249.00
Mar 31, 2025 1,610.00
Dec 31, 2024 1,351.00
Sep 30, 2024 437.00
Jun 30, 2024 409.00
Mar 31, 2024 14,267.00
Dec 31, 2023 229.00
Sep 30, 2023 149.00
Jun 30, 2023 642.00
Mar 31, 2023 849.00
Dec 31, 2022 -145.00
Sep 30, 2022 -1,002.00
Jun 30, 2022 -1,903.00
Mar 31, 2022 -2,531.00
Dec 31, 2021 -2,039.00
Sep 30, 2021 -1,612.00
Jun 30, 2021 -1,079.00